The Value of OCT and OCTA as Potential Biomarkers for Preclinical Alzheimer’s Disease: A Review Study
Authors:
- Inés López-CuencaInés López-Cuenca
- Elena Salobrar-GarcíaElena Salobrar-García
- Lorena Elvira-HurtadoLorena Elvira-Hurtado
- José A. Fernández-AlbarralJFJosé A. Fernández-Albarral
- Lidia Sánchez-PueblaLidia Sánchez-Puebla
- Juan J. SalazarJuan J. Salazar
- José M. RamírezJosé M. Ramírez
- Ana I. RamírezAna I. Ramírez
- Rosa de HozRosa de Hoz
Open Access
Abstract
Preclinical Alzheimer’s disease (AD) includes cognitively healthy subjects with at least one positive biomarker: reduction in cerebrospinal fluid Aβ42 or visualization of cerebral amyloidosis by positron emission tomography imaging. The use of these biomarkers is expensive, invasive, and not always possible. It has been shown that the retinal changes measured by optical coherence tomography (OCT) and OCT-angiography (OCTA) could be biomarkers of AD. Diagnosis in early stages before irreversible AD neurological damage takes place is important for the development of new therapeutic interventions. In this review, we summarize the findings of different published studies using OCT and OCTA in participants with preclinical AD. To date, there have been few studies on this topic and they are methodologically very dissimilar. Moreover, these include only two longitudinal studies. For these reasons, it would be interesting to unify the methodology, make the inclusion criteria more rigorous, and conduct longer longitudinal studies to assess the evolution of these subjects. If the results were consistent across repeated studies with the same methodology, this could provide us with insight into the value of the retinal changes observed by OCT/OCTA as potential reliable, cost-effective, and noninvasive biomarkers of preclinical AD.Keywords
Funding Information
- Instituto de Salud Carlos III (RD16/0008/0005)
- Ministerio de Ciencia e Innovación (RED2018-102499-T)
- Universidad Complutense de Madrid (CT42/18-CT43/18)
- Ministerio de Ciencia, Innovación y Universidades (FPU17/01023)
This publication has 69 references indexed in Scilit:
- Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s diseaseTranslational Psychiatry, 2013
- Comparison of the Optic Nerve Imaging by Time-Domain Optical Coherence Tomography and Fourier-Domain Optical Coherence Tomography in Distinguishing Normal Eyes From Those With GlaucomaJournal of Glaucoma, 2013
- Alzheimer’s Disease and GlaucomaJournal of Glaucoma, 2013
- Neuropathological Alterations in Alzheimer DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomographyClinical Ophthalmology, 2010
- Soluble and Mature Amyloid Fibrils in Drusen DepositsInvestigative Ophthalmology & Visual Science, 2010
- Retinal Abnormalities in Early Alzheimer’s DiseaseInvestigative Ophthalmology & Visual Science, 2007
- How common are the “common” neurologic disorders?Neurology, 2007
- Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculaturesJournal of Anatomy, 2005
- Optic-Nerve Degeneration in Alzheimer's DiseaseNew England Journal of Medicine, 1986